Genomma Lab Internacional, S.A.B. de C.V. (FRA:GEKA)

Market Cap	715.31M -23.5%
Revenue (ttm)	853.90M -9.5%
Net Income	81.63M -16.1%
EPS	0.08 -13.9%
Shares Out	n/a
PE Ratio	8.76
Forward PE	6.50
Dividend	0.04 (5.36%)
Ex-Dividend Date	Jun 26, 2026

Volume	n/a
Open	0.7150
Previous Close	0.7050
Day's Range	0.7150 - 0.7150
52-Week Range	0.6850 - 1.0900
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Jul 22, 2026

About Genomma Lab Internacional

Genomma Lab Internacional, S.A.B. de C.V., together with its subsidiaries, provides pharmaceutical and personal care products primarily in Mexico and internationally. It develops, sells, and markets a range of branded products in the categories of anti-acne products, self-diagnosis, antibacterial, cream to improve the texture of scarred skin, shampoos, dandruff shampoos, soaps, razors, products to prevent hair loss, ointment for muscle pain, anti-fungal treatments for the relief of colitis, products to counter stress levels, anti-wrinkles, anta...

• Industry: Pharmaceutical Preparations
• Founded: 1996
• Employees: 1,643
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: GEKA

Financial Performance

In 2025, Genomma Lab Internacional's revenue was 17.54 billion, a decrease of -5.73% compared to the previous year's 18.61 billion. Earnings were 1.61 billion, an increase of 8.10%.

Financial numbers in MXN

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Jul 28, 2026

Data Sources Report a data error